UMBI Research Spotlight No.10/2026
Next-Gen AIH Therapy: Whole-Cell MSCs vs. Cell-Free Extracellular Vesicles UMBI is pleased to highlight a review article examining potential of mesenchymal stem/stromal cells (MSCs) …
Next-Gen AIH Therapy: Whole-Cell MSCs vs. Cell-Free Extracellular Vesicles UMBI is pleased to highlight a review article examining potential of mesenchymal stem/stromal cells (MSCs) …
30 Oktober 2026, KUALA LUMPUR – Institut Biologi Molekul Perubatan UKM (UMBI) menganjurkan Program Bicara Felo Utama UMBI bertajuk “Behind the Winning Proposals: Lessons, Strategies …
UMBI Memperkasa Kepakaran Penjujukan Genom Melalui Program Sijil Profesional 2026 29 Oktober 2026, KUALA LUMPUR – UMBI telah berjaya menganjurkan Program Sijil Profesional Penjujukan Genom …
Drug Use and False-Positive iFOBT in Colorectal Cancer Screening UMBI is pleased to highlight a study from The Malaysian Cohort investigating whether commonly prescribed …
KUALA LUMPUR, 30 September 2026 – Institut Biologi Molekul Perubatan UKM (UMBI) menerima kunjungan kepimpinan tertinggi Johor Corporation (JCorp), KPJ Healthcare dan KPJ University …
The COVGEN Study: Risk Factors & Variant Impacts on COVID-19 in Malaysia UMBI is pleased to share a published research article of the COVGEN …
Targeting Molecular Drivers of Diabesotension for Personalized Therapy UMBI researcher Dr. Muhammad-Redha Abdullah-Zawawi and his team have published a commentary exploring the molecular links …
The AGR2-ESR1 Genetic Axis in Breast Cancer Progression UMBI is pleased to share a recent peer-reviewed publication by our researchers led by Ts. Dr. …
CHERAS, 26 Julai 2026 – Institut Biologi Molekul Perubatan UKM (UMBI), dengan kerjasama Fakulti Sains Kesihatan dan Fakulti Perubatan UKM, telah melaksanakan Projek Menangani …
𝐊𝐔𝐀𝐋𝐀 𝐋𝐔𝐌𝐏𝐔𝐑, 𝟏 𝐉𝐮𝐥𝐚𝐢 𝟐𝟎𝟐𝟔 – Institut Biologi Molekul Perubatan UKM (UMBI) telah menerima kunjungan daripada dua tokoh terkemuka dunia dalam bidang perubatan dan penyelidikan …